10x Genomics, Inc. (TXG) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 26.12M | 40.78M | 43.21M | 17.71M | 34.35M | -6.75M | 21.64M | 7.5M | -15.72M | 25.76M | -25.3M | -11.53M |
| Operating CF Margin % | 17.32% | 24.56% | 29% | 10.24% | 22.18% | -4.09% | 14.27% | 4.9% | -11.15% | 14% | -16.47% | -7.85% |
| Operating CF Growth % | -23.96% | 704.28% | 99.69% | 136.23% | 318.45% | -126.2% | 185.52% | 165.04% | -281.21% | 87.7% | -164.58% | 32.05% |
| Net Income | -13.47M | -16.25M | -27.47M | 34.54M | -34.36M | -49.03M | -35.75M | -37.9M | -59.95M | -48.95M | -92.99M | -62.41M |
| Depreciation & Amortization | 11.91M | 12.1M | 12.25M | 9.65M | 9.81M | 10.56M | 10.75M | 10.9M | 11.49M | 11.71M | 11.42M | 11.88M |
| Stock-Based Compensation | 22.64M | 25.22M | 25.26M | 27.56M | 31.08M | 32.54M | 33.59M | 38.49M | 36.13M | 38.92M | 40.23M | 45.7M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -250K | 1.13M | 1.4M | -351K | -461K | 552K | 64K | 66K | 2.9M | 7.02M | -143K | 3.25M |
| Working Capital Changes | 5.29M | 18.58M | 31.77M | -53.69M | 28.28M | -1.38M | 12.99M | -4.07M | -6.3M | 17.07M | 16.17M | -9.93M |
| Change in Receivables | 26.11M | 14.1M | 22.91M | -65.89M | 35.33M | -4.37M | 7.68M | 122K | 23.52M | -10.97M | -16.16M | -9.75M |
| Change in Inventory | 2.7M | 5.58M | 7.29M | 7.03M | 8.06M | 9.62M | -4.26M | -5.2M | -9.94M | 7.61M | 2.57M | -1.86M |
| Change in Payables | 4.78M | -5.42M | -196K | 6.04M | -2.55M | -13.4M | 4.34M | 1.12M | 4.58M | -3.21M | -4.13M | 2.1M |
| Cash from Investing | -1.31M | -1.8M | -8.8M | -939K | -1.89M | -51.59M | -3.62M | 11.95M | 10.63M | 13.1M | 4.9M | -4.46M |
| Capital Expenditures | -1.6M | -1.78M | -687K | -1.58M | -1.89M | -2.72M | -3.89M | -3.88M | -2.91M | -3.45M | -15.24M | -25.36M |
| CapEx % of Revenue | 1.06% | 1.07% | 0.46% | 0.91% | 1.22% | 1.65% | 2.56% | 2.53% | 2.06% | 1.88% | 9.92% | 17.27% |
| Acquisitions | 0 | 0 | -8.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -652K | 0 | -49.36M | 0 | -48.88M | 0 | 0 | 0 | 0 | -200K | 0 |
| Cash from Financing | -8.42M | 2.24M | 617K | 3.52M | 422K | 4.52M | 156K | 4.6M | 1.64M | 5.61M | 4.37M | 7.1M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 273K | 2.24M | 617K | 0 | 422K | 4.52M | 156K | 4.6M | 1.64M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -8.69M | 0 | 0 | 3.52M | 0 | 0 | 0 | 0 | 0 | 5.61M | 4.37M | 7.1M |
| Net Change in Cash | 16.32M | 41.26M | 35M | 20.65M | 32.99M | -54.09M | 18.34M | 24.04M | -3.5M | 44.55M | -16.11M | -8.94M |
| Free Cash Flow | 24.52M | 39M | 42.53M | 16.13M | 32.46M | -9.46M | 17.75M | 3.62M | -18.64M | 22.31M | -40.74M | -36.88M |
| FCF Margin % | 16.26% | 23.49% | 28.54% | 9.33% | 20.96% | -5.73% | 11.71% | 2.36% | -13.22% | 12.13% | -26.52% | -25.12% |
| FCF Growth % | -24.45% | 512.09% | 139.56% | 345.83% | 274.18% | -142.42% | 143.57% | 109.81% | -114.59% | 185.76% | 11.7% | 16.52% |
| FCF per Share | 0.19 | 0.31 | 0.34 | 0.13 | 0.26 | -0.08 | 0.15 | 0.03 | -0.16 | 0.19 | -0.35 | -0.32 |
| FCF Conversion (FCF/Net Income) | -1.94x | -2.51x | -1.57x | 0.51x | -1.00x | 0.14x | -0.61x | -0.20x | 0.26x | -0.53x | 0.27x | 0.18x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 456K | 617K | 856K | 462K | -4.86M | 2.82M | 1.08M | 961K | 476K | 599K | 1.3M |